Janssen ‘will continue endeavors to the Korean society’
By Son, Hyung-Min | translator Eo, Yun-Ho
23.10.23 12:02:16
가나다라
0
Janssen Korea holds press conference celebrating the 40th year of this establishment in Korea on the 23rd
Will contribute to Korean society through the provision of innovative pharmaceuticals, fostering talent, and open innovation
Cherry Huang, Managing Director of Janssen Korea, “Janssen has shown strengths in various therapeutic areas, and will seek cogrowth with the future Korean society.”
▲ Janssen Korea held a press conference celebrating its 40th year of establishment at the Seoul Plaza Hotel on the 23rd
Janssen, which has succeeded in developing treatments in various areas including mental health, autoimmune diseases, and oncology over the past 40 years, emphasized that it will continue to contribute to Korean society by providing innovative medicines and fostering talent.
On the 23rd, the company held a press conference celebrating its 40th year of establishment at the Seoul Plaza Hotel.
At the event, the company introduced the major achievements it had made in the past 40 years and their significance in each of its therapeutic areas. Managing Director of Janssen Korea Cherry Huang, as well as Chris Hourigan, the Company Group Chairman, Pharmaceuticals, Asia Pacific, Jung-Hee Le
Son, Hyung-Min(shm@dailypharm.com)
If you want to see the full article, please JOIN US (click)